Robert Olstein Zimmer Biomet Holdings, Inc. Transaction History

Olstein Capital Management, L.P.

$588 Million
Q3 2024

A detailed history of Robert Olstein (Olstein Capital Management, L.P.) transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Olstein Capital Management, L.P. holds 80,000 shares of ZBH stock, worth $8.74 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares

80,000

Previous 77,400 3.36%

Holding current value

$8.74 Million

Previous $8.4 Million 2.81%

% of portfolio

1.47%

Previous 1.49%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$104.47 - $116.17 $271,622 - $302,042	2,600 Added 3.36%	80,000 $8.64 Million
Q2 2024 Jul 10, 2024	BUY	$106.25 - $130.01 $1.32 Million - $1.61 Million	12,400 Added 19.08%	77,400 $8.4 Million
Q1 2024 Apr 19, 2024	SELL	$119.98 - $132.61 $196,167 - $216,817	-1,635 Reduced 2.45%	65,000 $8.58 Million
Q4 2023 Jan 25, 2024	BUY	$102.72 - $121.7 $989,707 - $1.17 Million	9,635 Added 16.9%	66,635 $8.11 Million
Q3 2023 Oct 10, 2023	BUY	$110.76 - $143.18 $1.11 Million - $1.43 Million	10,000 Added 21.28%	57,000 $6.4 Million
Q2 2023 Jul 27, 2023	SELL	$126.43 - $145.6 $1.01 Million - $1.16 Million	-8,000 Reduced 14.55%	47,000 $6.84 Million
Q1 2023 May 02, 2023	SELL	$121.91 - $130.94 $243,820 - $261,880	-2,000 Reduced 3.51%	55,000 $7.11 Million
Q4 2022 Feb 06, 2023	SELL	$104.7 - $128.4 $3.3 Million - $4.04 Million	-31,500 Reduced 35.59%	57,000 $7.27 Million
Q3 2022 Oct 19, 2022	SELL	$101.65 - $119.27 $9.81 Million - $11.5 Million	-96,500 Reduced 52.16%	88,500 $9.25 Million
Q2 2022 Jul 25, 2022	BUY	$102.23 - $133.85 $8.69 Million - $11.4 Million	85,000 Added 85.0%	185,000 $21.7 Million
Q1 2022 May 13, 2022	SELL	$108.42 - $129.58 $3.32 Million - $3.97 Million	-30,600 Reduced 23.43%	100,000 $12.8 Million
Q4 2021 Jan 27, 2022	BUY	$115.43 - $146.63 $3.53 Million - $4.49 Million	30,600 Added 30.6%	130,600 $16.6 Million
Q3 2021 Nov 12, 2021	BUY	$136.35 - $158.76 $4.5 Million - $5.24 Million	33,000 Added 49.25%	100,000 $14.6 Million
Q2 2021 Aug 10, 2021	SELL	$152.95 - $173.41 $611,800 - $693,640	-4,000 Reduced 5.63%	67,000 $10.8 Million
Q4 2020 Feb 12, 2021	SELL	$128.25 - $151.41 $275,737 - $325,531	-2,150 Reduced 2.94%	71,000 $10.9 Million
Q3 2020 Nov 12, 2020	SELL	$113.59 - $141.68 $778,091 - $970,508	-6,850 Reduced 8.56%	73,150 $9.96 Million
Q2 2020 Aug 12, 2020	SELL	$87.02 - $133.4 $374,186 - $573,620	-4,300 Reduced 5.1%	80,000 $9.55 Million
Q1 2020 May 12, 2020	BUY	$78.28 - $155.73 $414,884 - $825,369	5,300 Added 6.71%	84,300 $8.52 Million
Q4 2019 Feb 12, 2020	SELL	$127.4 - $146.83 $178,360 - $205,562	-1,400 Reduced 1.74%	79,000 $11.8 Million
Q3 2019 Nov 08, 2019	SELL	$113.33 - $138.46 $3.01 Million - $3.68 Million	-26,600 Reduced 24.86%	80,400 $11 Million
Q2 2019 Jul 31, 2019	BUY	$108.87 - $125.09 $762,090 - $875,630	7,000 Added 7.0%	107,000 $12.6 Million
Q1 2019 May 08, 2019	SELL	$97.5 - $125.79 $667,875 - $861,661	-6,850 Reduced 6.41%	100,000 $12.8 Million
Q4 2018 Feb 08, 2019	BUY	$94.4 - $126.76 $33,040 - $44,366	350 Added 0.33%	106,850 $11.1 Million
Q3 2018 Nov 07, 2018	SELL	$108.41 - $127.64 $3.78 Million - $4.45 Million	-34,890 Reduced 24.68%	106,500 $14 Million
Q2 2018 Aug 08, 2018	BUY	$102.12 - $114.04 $393,162 - $439,054	3,850 Added 2.8%	141,390 $15.8 Million
Q1 2018 May 04, 2018	SELL	$104.31 - $124.46 $487,127 - $581,228	-4,670 Reduced 3.28%	137,540 $15 Million
Q4 2017 Feb 08, 2018	BUY	$105.55 - $120.83 $1 Million - $1.15 Million	9,510 Added 7.17%	142,210 $17.2 Million
Q3 2017 Nov 08, 2017	BUY	$106.92 - $117.79 $14.2 Million - $15.6 Million	132,700	132,700 $15.5 Million

Others Institutions Holding ZBH

# of Institutions

1,080

Shares Held

179M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.9B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track Robert Olstein's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Olstein Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Olstein Capital Management, L.P. and Robert Olstein with notifications on news.

Account